Technical Analysis for SOLTF - Sosei Co. Ltd

Grade Last Price % Change Price Change
A 22.0800 -1.41% -0.3150
SOLTF closed down 1.41 percent on Friday, June 2, 2023, on 15 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Up

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
Pocket Pivot Bullish Swing Setup -1.41%
Narrow Range Bar Range Contraction -1.41%
Stochastic Reached Overbought Strength -1.41%
Gapped Up Strength -1.41%
Overbought Stochastic Strength -1.41%
Slingshot Bullish Bullish Swing Setup -0.38%
Narrow Range Bar Range Contraction -0.38%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Sosei Co. Ltd Description

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.


Keywords: Health Biopharmaceutical Life Sciences Pharmaceutical Industry Neurological Disorders Asthma Chronic Obstructive Pulmonary Disease Obesity Astrazeneca Inflammatory Bowel Disease Pfizer Diabetes Mellitus Biopharmaceutical Products Genentech Neurological Diseases Abbvie Inc.

Is SOLTF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 22.782
52 Week Low 15.9
Average Volume 2,050
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 20.6579
10-Day Moving Average 21.3490
Average True Range 0.5579
RSI (14) 62.26
ADX 29.04
+DI 60.5395
-DI 33.7238
Chandelier Exit (Long, 3 ATRs) 21.1083
Chandelier Exit (Short, 3 ATRs) 19.3386
Upper Bollinger Bands 22.6732
Lower Bollinger Band 18.6426
Percent B (%b) 0.85
BandWidth 19.5112
MACD Line 1.0093
MACD Signal Line 0.8799
MACD Histogram 0.1294
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.0800
Resistance 3 (R3) 22.0800 22.0800 22.0800
Resistance 2 (R2) 22.0800 22.0800 22.0800 22.0800
Resistance 1 (R1) 22.0800 22.0800 22.0800 22.0800 22.0800
Pivot Point 22.0800 22.0800 22.0800 22.0800 22.0800
Support 1 (S1) 22.0800 22.0800 22.0800 22.0800 22.0800
Support 2 (S2) 22.0800 22.0800 22.0800 22.0800
Support 3 (S3) 22.0800 22.0800 22.0800
Support 4 (S4) 22.0800